Advertisement

Picture Universal Medica Innovations Days 2015 Paris France October Middle
Organisation › Details

Antisense Pharma GmbH

Antisense Pharma is a pioneer in the development of antisense drugs. Discovered with the help of modern platform technology, the drugs effectively prevent disease-associated proteins to originate. This allows to tackle fatal diseases like cancer at their roots - fighting them causally rather than symptomatically.

The product pipeline comprises agents against malignant brain tumors, colorectal carcinoma, pancreatic carcinoma and malignant melanoma as well as other forms of tumors in various stages of clinical and pre-clinical development. Antisense Pharma has been awarded the Bavarian Innovation Prize as well as the German Founders Award. In addition to MIG-Fonds and along with private investors other venture capital companies like Global Chance Fund, Global Asset Fund, S-Refit, TechnologiebeteiligungsGesellschaft mbH and the Techonologie Beteiligunsgfonds GmbH & Co. KG. are actively involved in Antisense Pharma. *

 

Period Start 1998-01-01 established
Period End 2013-09-30 renamed
  Group Isarna Therapeutics GmbH
  Today Isarna Therapeutics GmbH
  Successor Isarna Therapeutics GmbH
Products Industry antisense drug
  Industry 2 cancer drug
Persons Person Calais, Philippe (Antisense Pharma 201205– Managing Director CEO before Roche + ICI et al)
  Person 2 Heinrichs, Hubert (Antisense Pharma 201012 Managing Director)
     
Region Region Regensburg
  Country Germany
  Street 9 Josef-Engert-Str.
  City 93053 Regensburg
  Tel +49-941-9201-300
  Fax +49-941-9201-329
    Address record changed: 2010-12-22
     
Basic data Employees C: 51 to 100 (2008-10-01)
     
    * Document for »About Section«: Antisense Pharma GmbH. (11/08/07). "Press Release: €27 Million/$38 Million Venture Capital for Specialist in Cancer Therapeutics". Regensburg.
     
   
Record changed: 2014-03-20

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x80px

More documents for Isarna Therapeutics GmbH


To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [iito] – Putting Information into Context 560x130px




» top

Advertisements

Picture Universal Medica Innovations Days 2015 Paris France October 120x180px Picture EBD Group BIO Europe 2015 BEU Munich November 120x80px Picture BioM Munich Biomarker Conference 2015 München Germany December 120x180px Picture BIO Deutschland European Business Development Conference 120x240px Picture SwedenBIO Nordic Life Science Days 2015 Stockholm 600x60px Picture LSBC Central European Life Science Investment Conference 2015 120x240px Picture EBD Group BioPharm America 2015 BPA Boston September 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px